Taysha Gene Therapies
Experienced in both academia and the biopharma industry in development of gene therapy and viral vaccine candidates with deep manufacturing experience at Novartis and most recently at BridgeBio Pharma where he was SVP of Technical Development and Manufacturing.
This person is not in any teams
This person is not in any offices
Taysha Gene Therapies
Taysha Gene Therapies is on a mission to eradicate severe and life-threatening monogenic CNS disease. With a singular focus on developing curative medicines, they hope to rapidly translate their treatments from bench to bedside.